These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 24786485)
1. Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates. Li L; Liu Y; Wang J; Chen L; Zhang W; Yan X Drug Deliv; 2016; 23(1):79-87. PubMed ID: 24786485 [TBL] [Abstract][Full Text] [Related]
2. Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation. Chen L; Wang Y; Zhang J; Hao L; Guo H; Lou H; Zhang D Eur J Pharm Biopharm; 2014 May; 87(1):160-9. PubMed ID: 24333772 [TBL] [Abstract][Full Text] [Related]
3. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability. Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846 [TBL] [Abstract][Full Text] [Related]
4. Folate-modified bexarotene-loaded bovine serum albumin nanoparticles as a promising tumor-targeting delivery system. Qi L; Guo Y; Luan J; Zhang D; Zhao Z; Luan Y J Mater Chem B; 2014 Dec; 2(47):8361-8371. PubMed ID: 32262006 [TBL] [Abstract][Full Text] [Related]
5. Morphology, in vivo distribution and antitumor activity of bexarotene nanocrystals in lung cancer. Wang Y; Rong J; Zhang J; Liu Y; Meng X; Guo H; Liu H; Chen L Drug Dev Ind Pharm; 2017 Jan; 43(1):132-141. PubMed ID: 27588517 [TBL] [Abstract][Full Text] [Related]
6. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method. Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600 [TBL] [Abstract][Full Text] [Related]
7. Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy. Kurakula M; El-Helw AM; Sobahi TR; Abdelaal MY Int J Nanomedicine; 2015; 10():321-34. PubMed ID: 25609947 [TBL] [Abstract][Full Text] [Related]
8. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
9. Nanoformulation of dual bexarotene-tailed phospholipid conjugate with high drug loading. He R; Du Y; Ling L; Ismail M; Hou Y; Yao C; Li X Eur J Pharm Sci; 2017 Mar; 100():197-204. PubMed ID: 28088372 [TBL] [Abstract][Full Text] [Related]
10. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182 [TBL] [Abstract][Full Text] [Related]
11. Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies. Rahim H; Sadiq A; Khan S; Khan MA; Shah SMH; Hussain Z; Ullah R; Shahat AA; Ibrahim K Drug Des Devel Ther; 2017; 11():2443-2452. PubMed ID: 28860715 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches. Zhang H; Meng Y; Wang X; Dai W; Wang X; Zhang Q Drug Deliv; 2014 Dec; 21(8):588-94. PubMed ID: 24320001 [TBL] [Abstract][Full Text] [Related]
13. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension. Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096 [TBL] [Abstract][Full Text] [Related]
14. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat. Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729 [TBL] [Abstract][Full Text] [Related]
15. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
17. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation. Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Li P; Wang Y; Zeng F; Chen L; Peng Z; Kong LX Carbohydr Res; 2011 May; 346(6):801-6. PubMed ID: 21397214 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation. Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653 [TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Zhang J; Lv H; Jiang K; Gao Y Int J Pharm; 2011 Nov; 420(1):180-8. PubMed ID: 21878378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]